MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

Shenzhen, China, 4 March 2024 — MGI Tech, a company committed to building core tools and technology to lead life science, today proudly announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S (“Eurofins Genomics”), which has placed a corporate order of the revolutionary DNBSEQ-T20×2 (“T20”) ultra-high throughput sequencer, along with the genomics data center ZTRON Appliance and a range of MGI’s state-of-the-art laboratory automation products and systems. This marks the first corporate order of the T20 in the Europe region, signaling a significant advancement in precision health initiatives across the continent.

Image Credit: MGI

"We are thrilled to work with Eurofins Genomics to leverage T20's ultra-high throughput and remarkable cost-efficiency to empower large population genome projects across the world. With this partnership, we hope to improve accessibility of cost-effective sequencing to researchers globally," said Dr. Yong Hou, General Manager of MGI Europe and Africa, with enthusiasm.

Powered by MGI’s proprietary DNBSEQä technology, T20 represents a breakthrough in genetic sequencing by significantly reducing sequencing costs to below $100 per genome when running 50,000 WGS per year, garnering global attention. Specifically designed to address the most challenging sequencing scenarios, T20 caters to a wide array of high-throughput sequencing needs in scientific and clinical research,including WGS, WGBS, stLFR, single-cell sequencing, Stereo-seq, and more. Following its launch in February 2023, T20 has gained widespread adoption among globally leading research institutions and healthcare providers.

Eurofins Genomics was founded in 1990 and is part of the Eurofins Scientific Group, a life science company with laboratories in over 50 countries and over 55,000 employees. Eurofins Genomics is one of the key emerging players in specialty esoteric and molecular clinical diagnostic testing in Europe and the United States. Eurofins Genomics offers a portfolio of over 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostics.

The collaboration between MGI and Eurofins Genomics signifies a synergy of expertise and resources that promises to drive advancement in genomics research and clinical applications. Both organizations are poised to further facilitate the development of personalized medicine and the improvement of healthcare outcomes worldwide.

*For Research Use Only. Not for use in diagnostic procedures.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    MGI. (2024, March 06). MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies. News-Medical. Retrieved on May 28, 2024 from https://www.news-medical.net/news/20240306/MGI-Tech-and-Eurofins-Genomics-Partner-to-Elevate-Precision-Health-with-Revolutionary-DNBSEQ-T20c3972-Sequencer-and-Related-Technologies.aspx.

  • MLA

    MGI. "MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies". News-Medical. 28 May 2024. <https://www.news-medical.net/news/20240306/MGI-Tech-and-Eurofins-Genomics-Partner-to-Elevate-Precision-Health-with-Revolutionary-DNBSEQ-T20c3972-Sequencer-and-Related-Technologies.aspx>.

  • Chicago

    MGI. "MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies". News-Medical. https://www.news-medical.net/news/20240306/MGI-Tech-and-Eurofins-Genomics-Partner-to-Elevate-Precision-Health-with-Revolutionary-DNBSEQ-T20c3972-Sequencer-and-Related-Technologies.aspx. (accessed May 28, 2024).

  • Harvard

    MGI. 2024. MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies. News-Medical, viewed 28 May 2024, https://www.news-medical.net/news/20240306/MGI-Tech-and-Eurofins-Genomics-Partner-to-Elevate-Precision-Health-with-Revolutionary-DNBSEQ-T20c3972-Sequencer-and-Related-Technologies.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MGI Empowers Life Sciences Industry with Revolutionary What If Campaign at XXIIIrd International Congress of Genetics